Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$24.74 - $35.13 $549,475 - $780,237
22,210 Added 127.69%
39,604 $1.07 Million
Q4 2023

Feb 16, 2024

SELL
$21.62 - $37.21 $135,146 - $232,599
-6,251 Reduced 26.44%
17,394 $622,000
Q3 2023

Nov 15, 2023

BUY
$27.34 - $55.37 $646,454 - $1.31 Million
23,645 New
23,645 $668,000
Q1 2023

May 12, 2023

BUY
$18.09 - $27.61 $68,959 - $105,249
3,812 Added 14.48%
30,137 $793,000
Q4 2022

Feb 13, 2023

BUY
$16.24 - $26.38 $427,517 - $694,453
26,325 New
26,325 $492,000
Q2 2022

Aug 09, 2022

BUY
$21.39 - $35.9 $285,492 - $479,157
13,347 Added 82.57%
29,512 $779,000
Q1 2022

May 11, 2022

BUY
$24.84 - $36.12 $130,633 - $189,955
5,259 Added 48.22%
16,165 $552,000
Q4 2021

Feb 14, 2022

BUY
$33.38 - $59.25 $364,042 - $646,180
10,906 New
10,906 $380,000

Others Institutions Holding SDGR

About Schrodinger, Inc.


  • Ticker SDGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 62,028,400
  • Market Cap $1.23B
  • Description
  • Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...
More about SDGR
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.